🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

One week of being Champs

🚨 ACEP Members ED Accreditation Criteria are out and thanks to SAEM & SAEM AEMP a pharmacist is now required for all Level 1 & Level 2 sites - THIS is the work we're doing to advance EM pharmacy practice 👐acep.org/siteassets/sit…

We're trying steroids and vasopressin again in IHCA Small pilot study showing benefit, remains to be seen on a larger scale if the results hold up or not, but 38% vs 16% ROSC looks good sciencedirect.com/science/articl…

Super interesting concept using this guy’s antibodies + varespladib for making potentially powerful treatment for 🐍 envenoming. #MedTwitter #TwitteRx

Can you safely use propofol in patients with egg or soy allergies? See the answer below in my latest #PharmacyEducationBoard

Calling all practitioners, residents, great series discussing real cases and literature! There will be Pharmacists CE provided.

This is wild

🚨ID PHARM JOB ALERT🚨 UCHealth has a unique 0.5/0.5 Infectious Diseases / Emergency Department pharmacy position just posted! Come hang out with the coolest ID *and* ED teams and one of the only quaternary medical centers in the USA! careers.uchealth.org/jobs/16156369-…

New SRMA in-press with 6 studies comparing re-arrest rates post-ROSC btwn epi and norepi gtts with NE showing lower re-arrest rates and a non-significant increase is survival to discharge   Should likely be doing NE gtts in most everyone post-ROSC at this point

New study on post-RSI hypotension in elderly ED pts. No differences in PIH or 28-day mortality after matching but lower mortality with ketamine after a multivariable analysis. PIH rates went up (not surprisingly) in both arms with a + shock index bit.ly/3FeqTOy

I have to say, being able to push meds in the ED is a win-win for everyone. We free up RNs for other tasks, ensure safe admin, correct doses, etc We've essentially taken over sedations now and if a ED pharm is around we're pushing meds almost 100% of the time which is awesome

Is this the end of rivaroxaban for acute VTE? Lana Castellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025

Cobra Trial: #apixaban safer than #rivaroxaban for venous #thrombosis treatment #ISTH2025 ⁦Anticoagulation Forum⁩ ⁦Vasculearn Network⁩ ⁦The PERT Consortium®⁩ ⁦World Thrombosis Day⁩ ⁦Thrombosis Canada⁩ ⁦CanVECTOR Network⁩ ⁦European Thrombosis & Haemostasis Alliance (ETHA)⁩ ⁦C. Michael Gibson MD⁩ ⁦

This week, the CDC’s Advisory Committee on Immunization Practices (ACIP) met for the first time under new leadership appointed by RFK Jr. The session was marked by disruption, resignations, and concern from key medical organizations. Here’s a breakdown:

New study on arresting pt's with a-lines shows high ROSC in pt's with significant increases in MAP/DBP after epi compared to non-responders. Need to figure what to do for non-responders to incr chance of ROSC Good editorial on the study too bit.ly/4eLRMXv

ChatGPT less accurate than a pharmacist for DI questions Job are still safe👍 bit.ly/4kje6Zz

New study in press comparing efficacy and safety of DOACS vs warfarin in cancer pts with afib DOACs better in essentially every outcome measured

Check out our new segment on anti-amyloid mABs to learn why you need to be aware of these meds in the ED 👇 🧠 ADEs called ARIAs are non-specific, typically require MRI & can mimic stroke ⛔ Concomitant thrombolytics/anticoagulants are contraindicated annemergmed.com/article/S0196-…

New ED pharmD study on lytics for PE-arrest with both tPA and TNK pt's ROSC seen in 9/21 with tPA vs only 2/11 with TNK. Not a huge study (it's hard to find pts) but super interesting to see if another study comes out with similar tPA > TNK results bit.ly/4mbUqYG